Neurological Sciences

, Volume 39, Issue 4, pp 785–787 | Cite as

Orbital myositis as a manifestation of primary antiphospholipid syndrome

Letter to the Editor
  • 70 Downloads

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Miserocchi E, Baltatzis S, Foster CS (2001) Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol 131(4):451–456CrossRefPubMedGoogle Scholar
  2. 2.
    Durrani OM, Cameron-Swaby DA, Bowman S, Ainsworth JR (2001) Scleritis as the presenting sign of primary antiphospholipid syndrome. Eye (London, England) 15(Pt 4):558–559.  https://doi.org/10.1038/eye.2001.180 CrossRefGoogle Scholar
  3. 3.
    de Groot PG, Horbach DA, Simmelink MJ, van Oort E, Derksen RH (1998) Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant. Lupus 7(Suppl 2):S32–S36CrossRefPubMedGoogle Scholar
  4. 4.
    Willems GM, Janssen MP, Pelsers MM, Comfurius P, Galli M, Zwaal RF, Bevers EM (1996) Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 35(43):13833–13842.  https://doi.org/10.1021/bi960657q CrossRefPubMedGoogle Scholar
  5. 5.
    Shoughy SS, Tabbara KF (2016) Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol 30(2):117–121.  https://doi.org/10.1016/j.sjopt.2016.02.001 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of Neurology, Incheon St. Mary’s HospitalCatholic University of KoreaIncheonSouth Korea

Personalised recommendations